Business Description
Avanos Medical Inc
NAICS : 339113
SIC : 3842
ISIN : US05350V1061
Description
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.35 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.25 | |||||
| Debt-to-EBITDA | 2.86 | |||||
| Interest Coverage | 3.86 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.81 | |||||
| Beneish M-Score | -2.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.8 | |||||
| 3-Year Book Growth Rate | 1.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.14 | |||||
| 9-Day RSI | 67.75 | |||||
| 14-Day RSI | 63.93 | |||||
| 6-1 Month Momentum % | -11.04 | |||||
| 12-1 Month Momentum % | -18.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.07 | |||||
| Quick Ratio | 2.16 | |||||
| Cash Ratio | 0.63 | |||||
| Days Inventory | 164.93 | |||||
| Days Sales Outstanding | 60.48 | |||||
| Days Payable | 57.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.8 | |||||
| Shareholder Yield % | 4.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.71 | |||||
| Operating Margin % | 6.68 | |||||
| Net Margin % | -6.52 | |||||
| FCF Margin % | 4.31 | |||||
| ROE % | -4.39 | |||||
| ROA % | -3.19 | |||||
| ROIC % | 2.15 | |||||
| ROC (Joel Greenblatt) % | 14.77 | |||||
| ROCE % | 3.78 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 33.28 | |||||
| PS Ratio | 1.22 | |||||
| PB Ratio | 0.81 | |||||
| Price-to-Tangible-Book | 5.25 | |||||
| Price-to-Free-Cash-Flow | 27.79 | |||||
| Price-to-Operating-Cash-Flow | 19.07 | |||||
| EV-to-EBIT | 20.6 | |||||
| EV-to-EBITDA | 11.39 | |||||
| EV-to-Revenue | 1.44 | |||||
| EV-to-FCF | 33.44 | |||||
| Price-to-Projected-FCF | 1.29 | |||||
| Price-to-Graham-Number | 2.79 | |||||
| Price-to-Net-Current-Asset-Value | 45.32 | |||||
| Earnings Yield (Greenblatt) % | 4.85 | |||||
| FCF Yield % | 3.7 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:AVNS
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avanos Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 849.9 | ||
| EPS (TTM) ($) | -1.19 | ||
| Beta | 1.03 | ||
| Volatility % | 35.98 | ||
| 14-Day RSI | 63.93 | ||
| 14-Day ATR ($) | 0.620641 | ||
| 20-Day SMA ($) | 21.365 | ||
| 12-1 Month Momentum % | -18.55 | ||
| 52-Week Range ($) | 17.235 - 31.99 | ||
| Shares Outstanding (Mil) | 46.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avanos Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avanos Medical Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avanos Medical Inc Frequently Asked Questions
What is Avanos Medical Inc(AVNS)'s stock price today?
The current price of AVNS is $21.30. The 52 week high of AVNS is $31.99 and 52 week low is $17.24.
When is next earnings date of Avanos Medical Inc(AVNS)?
The next earnings date of Avanos Medical Inc(AVNS) is 2024-02-21 Est..
Does Avanos Medical Inc(AVNS) pay dividends? If so, how much?
Avanos Medical Inc(AVNS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers